We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
-0.06%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$1.95B
AUM Growth
+$5.23M
Cap. Flow
+$15.4M
Cap. Flow %
0.79%
Top 10 Hldgs %
25.95%
Holding
309
New
21
Increased
82
Reduced
130
Closed
6

Top Buys

Rank Stock Value
1
AXP icon
American Express
AXP
+$15.2M
2
OXY icon
Occidental Petroleum
OXY
+$13.2M
3
DEO icon
Diageo
DEO
+$3.58M
4
PFE icon
Pfizer
PFE
+$3.35M
5
MCD icon
McDonald's
MCD
+$3.3M

Sector Composition

Rank Sector Weight
1 Healthcare 15.33%
2 Technology 14.57%
3 Energy 12.11%
4 Financials 12.03%
5 Industrials 11.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAX icon
26
Baxter International
BAX
$11.2B
$22.9M 1.17%
586,465
+38,858
+7% +$1.58M
PII icon
27
Polaris
PII
$4.22B
$22.7M 1.16%
151,461
-6,629
-4% -$958K
GE icon
28
GE Aerospace
GE
$354B
$22.4M 1.15%
182,676
+6,260
+4% +$780K
MMM icon
29
3M
MMM
$88.1B
$20.7M 1.06%
174,959
-1,069
-0.6% -$129K
AFL icon
30
Aflac
AFL
$62.9B
$20.5M 1.05%
703,176
+44,624
+7% +$1.36M
WMB icon
31
Williams Companies
WMB
$91.1B
$20.3M 1.04%
366,850
-10,721
-3% -$616K
DEO icon
32
Diageo
DEO
$46.9B
$19.1M 0.98%
165,575
+29,543
+22% +$3.58M
AIG icon
33
American International
AIG
$41.5B
$18.8M 0.97%
348,884
-18,259
-5% -$998K
ABBV icon
34
AbbVie
ABBV
$448B
$18.7M 0.96%
324,320
-25,097
-7% -$1.39M
VFC icon
35
VF Corp
VFC
$6.74B
$18.5M 0.95%
297,988
-4,436
-1% -$265K
MRK icon
36
Merck
MRK
$315B
$17.5M 0.9%
309,027
-41,078
-12% -$2.31M
ORCL icon
37
Oracle
ORCL
$362B
$16.8M 0.86%
438,227
-11,334
-3% -$459K
BP icon
38
BP
BP
$112B
$16.4M 0.84%
454,865
+21,053
+5% +$834K
SNY icon
39
Sanofi
SNY
$105B
$15.1M 0.78%
268,335
+8,044
+3% +$432K
AXP icon
40
American Express
AXP
$238B
$14.8M 0.76%
+168,917
New +$15.2M
BAC icon
41
Bank of America
BAC
$432B
$14.3M 0.73%
839,635
-22,754
-3% -$362K
VOD icon
42
Vodafone
VOD
$35.7B
$14M 0.72%
425,518
+26,095
+7% +$870K
ESRX
43
DELISTED
Express Scripts Holding Company
ESRX
$13.4M 0.69%
189,574
+11,477
+6% +$818K
DVN icon
44
Devon Energy
DVN
$51.8B
$13M 0.67%
190,574
-1,731
-0.9% -$129K
OXY icon
45
Occidental Petroleum
OXY
$57.2B
$12.7M 0.65%
+138,037
New +$13.2M
DHR icon
46
Danaher
DHR
$126B
$12.4M 0.64%
243,756
+18,946
+8% +$974K
ACN icon
47
Accenture
ACN
$85.7B
$12.3M 0.63%
150,925
+3,962
+3% +$318K
GOOG icon
48
Alphabet (Google) Class C
GOOG
$4.17T
$12.2M 0.62%
419,248
+10,409
+3% +$301K
CL icon
49
Colgate-Palmolive
CL
$73.3B
$12.1M 0.62%
185,696
-1,270
-0.7% -$83.8K
TEVA icon
50
Teva Pharmaceuticals
TEVA
$35.1B
$11.6M 0.59%
215,312
-4,387
-2% -$232K

Similar funds

HM Payson & Co's Q3 2014 Portfolio in Review

As of Q3 2014, HM Payson & Co held 309 positions worth $1.95B, up 0.27% from $1.95B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

HM Payson & Co's Q3 2014 filing shows 21 new, 82 increased, 130 reduced and 6 closed positions. Its largest new stake was American Express: 168,917 shares worth $14.8M. The largest sale was ConocoPhillips, an estimated $5.73M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Energy.

  • HM Payson & Co's largest Q3 2014 buy was American Express: 168,917 shares worth $14.8M.
  • HM Payson & Co added most to Diageo in Q3 2014, an estimated $3.58M increase.
  • HM Payson & Co's biggest Q3 2014 reduction was ConocoPhillips, cutting an estimated $5.73M.
  • HM Payson & Co fully exited EOG Resources in Q3 2014, selling an estimated $1.07M.
  • HM Payson & Co's ten largest holdings make up 26% of its $1.95B portfolio in Q3 2014.
  • HM Payson & Co opened 21 new positions and closed 6 in Q3 2014.
  • HM Payson & Co's portfolio value rose 0.27% quarter-over-quarter to $1.95B.

Based on HM Payson & Co's 13F filing for Q3 2014, filed 12 Nov 2014.